LEO Pharma has gained the US Food and Drug Administration (FDA) approval for its Anzupgo (delgocitinib), a 20mg/g cream for the topical treatment of moderate-to-severe chronic hand eczema (CHE) in adults.
Sun Pharmaceuticals has announced that Leqselvi (deuruxolitinib) 8mg tablets is now available to healthcare providers and individuals affected by severe alopecia areata in the US.
Connect Biopharma announced that its collaborator and exclusive licensee, Simcere Pharmaceutical has submitted a New Drug Application (NDA) for rademikibart to China's National Medical Products Administration (NMPA).
Abeona Therapeutics has announced receipt of the US Food and Drug Administration (FDA) approval for gene-modified cellular sheet therapy Zevaskyn for the wound treatment in both adult and paediatric patients suffering from recessive dystrophic epidermolysis bullosa (RDEB), a serious genetic skin condition.
Health Canada has granted approval for Arcutis’ topical formulation Zoryve (roflumilast cream 0.15%) for mild to moderate atopic dermatitis (AD) treatment in adults and paediatrics aged six years and above.
DEBRA Research and LEO Pharma have announced a non-exclusive strategic collaboration aiming to improve scouting capabilities and offer extra capacity to propel the development of therapies for Epidermolysis Bullosa (EB).
Torii Pharmaceutical has submitted a new drug application (NDA) for TO-208 in Japan, targeting the treatment of molluscum contagiosum, a common and highly contagious skin disease.
The US Food and Drug Administration (FDA) has accepted for review the supplemental biologics license application (sBLA) for Sanofi and Regeneron’s Dupixent (dupilumab) to treat chronic spontaneous urticaria (CSU) in adults and children aged 12 and above, particularly for those whose condition persists despite H1 antihistamine treatment.
The US Food and Drug Administration (FDA) has granted approval for Fresenius Kabi and Formycon’s Otulfi (ustekinumab-aauz), a ustekinumab biosimilar to the reference medicine Stelara (ustekinumab).
Hyphens Pharma has launched Ceradan Advanced Hand Balm, a new addition to its skincare range, specifically designed to combat hand eczema.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.